ArticlebioRxiv : the preprint server for biology2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy.
Lutz Gieselmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.